中国医院用药评价与分析
中國醫院用藥評價與分析
중국의원용약평개여분석
Evaluation and Analysis of Drug-Use in Hospitals of China
2015年
10期
1328-1330
,共3页
头孢唑林%销售金额%用药频度%日均费用%分析
頭孢唑林%銷售金額%用藥頻度%日均費用%分析
두포서림%소수금액%용약빈도%일균비용%분석
Cefazolin%Consumption sum%DDDs%DDC%Analysis
目的:评价头孢唑林在上海地区医院的应用现状和趋势。方法:对2011—2013年上海市119家医院头孢唑林的销售金额、用药频度( defined daily dose system,DDDs)、日均费用( daily drug cost,DDC)等进行统计和分析。结果:3年间,头孢唑林的份额在头孢菌素类药物中约占0.13%,销售金额呈逐年下降的趋势,DDDs略有上升,DDC略有下降,DDDs的复合年均增长率为2.31%。结论:应进一步规范头孢唑林的临床应用,以确保临床用药的安全和有效。
目的:評價頭孢唑林在上海地區醫院的應用現狀和趨勢。方法:對2011—2013年上海市119傢醫院頭孢唑林的銷售金額、用藥頻度( defined daily dose system,DDDs)、日均費用( daily drug cost,DDC)等進行統計和分析。結果:3年間,頭孢唑林的份額在頭孢菌素類藥物中約佔0.13%,銷售金額呈逐年下降的趨勢,DDDs略有上升,DDC略有下降,DDDs的複閤年均增長率為2.31%。結論:應進一步規範頭孢唑林的臨床應用,以確保臨床用藥的安全和有效。
목적:평개두포서림재상해지구의원적응용현상화추세。방법:대2011—2013년상해시119가의원두포서림적소수금액、용약빈도( defined daily dose system,DDDs)、일균비용( daily drug cost,DDC)등진행통계화분석。결과:3년간,두포서림적빈액재두포균소류약물중약점0.13%,소수금액정축년하강적추세,DDDs략유상승,DDC략유하강,DDDs적복합년균증장솔위2.31%。결론:응진일보규범두포서림적림상응용,이학보림상용약적안전화유효。
OBJECTIVE:To evaluate the utilization and tendency of cefazolin in 119 hospitals of Shanghai. METHODS:The utilization of cefazolin in 119 hospitals of Shanghai during 2011-2013 was statistically analyzed in respect of consumption sum, defined daily dose system( DDDs) and daily defined cost( DDC) , etc.RESULTS:During the three years, the market share of cefazolin took up about 0.13% of cephalosporins, but the consumption sum decreased yearly; DDDs had a slight increase while DDC had a slight decrease, CAGA of DDDs was 2.31%. CONCLUSIONS:The clinical application of cefazolin should be further regulated, so as to ensure the effective, safe and economical medication in clinic.